Open AccessPredictive biomarkers may help individualize treatment for patients with follicular lymphoma
Author(s) -
Barton Mary Kay
Publication year - 2013
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.21197
Subject(s) - rituximab , medicine , follicular lymphoma , oncology , bortezomib , hematology , lymphoma , follicular phase , biomarker , progression free survival , overall survival , multiple myeloma , biochemistry , chemistry